Linesight was engaged by one of the leading biopharmaceutical companies to provide full cost management services for the construction of its new pharmaceutical manufacturing facility in Shanghai. The 100,000 sq.m. facility of our confidential client is dedicated to the production of mRNA vaccines in China.
Linesight established a secondary review system to ensure that cost controls for accurate payment assessments were in place throughout the duration of the project. We conducted a secondary assessment of the costs, which involved procurement, change management and final account reviews. The team also delivered a comprehensive cost report with findings and recommendations to help deliver the project within budget.
In addition, our team reviewed the client’s policies and procedures to ensure compliance to governance requirements, such as anti-bribery and corruption, discrimination and environmental clauses.
Data
Helen Jie Shao
Country Manager - China
APAC
Relevant Projects
Latest News
20th September 2023
Influential Leaders Series – Fireside Chat with Jon Walker of Equinix
In the third instalment of Linesight’s ‘Influential Leaders Series’, John Carleton, Regional Director – ANZ, engaged in a Fireside Chat with Jon Walker, Senior Director – Commercial Management, APAC at Equinix.
Continue Reading18 September 2023
Linesight Expands reach into Canada with new Vancouver office
06 September 2023
CityBiz Interview on Lisa Mclntyre
06 September 2023
Linesight launches its Project Controls Pathway